|
|
|
Volumn 122, Issue 17, 2002, Pages 1671-1676
|
|
«New wonder pill» - What Norwegian newspapers write about new medications;«Ny vidunderpille!» - Hva skriver norske aviser om nye legemidler?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DONEPEZIL;
IRBESARTAN;
MONTELUKAST;
NEDOCROMIL SODIUM;
NEVIRAPINE;
PALIVIZUMAB;
PENCICLOVIR;
RALOXIFENE;
REBOXETINE;
RIVASTIGMINE;
RIZATRIPTAN;
ROFECOXIB;
SILDENAFIL;
TETRAHYDROLIPSTATIN;
TIBOLONE;
TOLTERODINE;
ZANAMIVIR;
DRUG;
ARTICLE;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG EFFECT;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG MANUFACTURE;
DRUG MARKETING;
HUMAN;
MEDICAL EXPERT;
MEDICAL LITERATURE;
NORWAY;
PUBLICATION;
RISK BENEFIT ANALYSIS;
ADVERTIZING;
ATTITUDE TO HEALTH;
BIBLIOMETRICS;
ECONOMICS;
HEALTH BEHAVIOR;
PUBLIC OPINION;
PUBLISHING;
RISK ASSESSMENT;
STANDARD;
ADVERTISING;
ATTITUDE TO HEALTH;
BIBLIOMETRICS;
DRUG COSTS;
DRUG INDUSTRY;
DRUG INFORMATION SERVICES;
HEALTH BEHAVIOR;
HUMANS;
JOURNALISM, MEDICAL;
NEWSPAPERS;
NORWAY;
PHARMACEUTICAL PREPARATIONS;
PUBLIC OPINION;
RISK ASSESSMENT;
|
|
EID: 0037198924
PISSN: 00292001
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (33)
|
